Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Since its development and release in 2019, the Society for Cardiovascular Angiography and
Interventions (SCAI) shock stage classification for adult patients has been widely cited and …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …

After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses
worldwide, yet it is an entity with incompletely understood pathophysiology and limited …

Congestion explains many of the signs and symptoms of acute heart failure (AHF) and
disease progression. However, accurate quantification of congestion is challenging in daily …

Summary of Key Points In this document, we propose a universal definition of heart failure
(HF) as the following: HF is a clinical syndrome with symptoms and or signs caused by a …

Sodium-glucose cotransporter-2 inhibitor therapy is well suited for initiation during the heart
failure hospitalization, owing to clinical benefits that accrue rapidly within days to weeks, a …